Financing Cash Flow
Biogen Financing Cash Flow increased by 68.0% to -$43.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 90.4%, from -$23.00M to -$43.80M. Over 3 years (FY 2021 to FY 2025), Financing Cash Flow shows an upward trend with a -47.6% CAGR.
Analysis
How to read this metric
A large negative value typically indicates a company is returning capital to shareholders or paying down debt, while a positive value suggests the company is raising external capital to fund operations or acquisitions.
Detailed definition
This metric represents the net flow of cash between a company and its capital providers, including shareholders and lend...
Peer comparison
Large-cap peers like Microsoft or Alphabet similarly show large negative financing outflows due to aggressive share repurchase programs and dividend distributions.
net_cash_from_financingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$564.50M | -$746.50M | $0.00 | -$16.50M | -$471.50M | -$1.25B | -$7.40M | -$43.40M | -$9.80M | $848.60M | -$439.60M | -$245.20M | -$6.60M | $0.00 | -$23.00M | -$11.70M | -$130.20M | -$137.00M | -$43.80M |
| QoQ Change | — | -32.2% | +100.0% | — | <-999% | -165.5% | +99.4% | -486.5% | +77.4% | >999% | -151.8% | +44.2% | +97.3% | +100.0% | — | +49.1% | <-999% | -5.2% | +68.0% |
| YoY Change | — | — | — | — | +16.5% | -67.7% | — | -163.0% | +97.9% | +167.8% | -912.9% | <-999% | -100.8% | — | +94.8% | +95.2% | <-999% | — | -90.4% |
Financing Cash Flow at Other Companies
Frequently Asked Questions
- What is Biogen's financing cash flow?
- Biogen (BIIB) reported financing cash flow of -$43.80M in Q1 2026.
- How has Biogen's financing cash flow changed year-over-year?
- Biogen's financing cash flow decreased by 90.4% year-over-year, from -$23.00M to -$43.80M.
- What is the long-term trend for Biogen's financing cash flow?
- Over 3 years (2021 to 2025), Biogen's financing cash flow has grown at a -47.6% compound annual growth rate (CAGR), from -$2.10B to -$301.90M.
- What does financing cash flow mean?
- The total amount of money a company spends or receives from borrowing debt and managing its own shares and dividends.